QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$33.61
-1.21% today
Updated 2026-04-29
Market cap
$6.93B
P/E ratio
16.48
P/S ratio
3.31x
EPS (TTM)
$2.04
Dividend yield
0.77%
52W range
$33 – $58
Volume
1.9M
WallStSmart proprietary scores
73
out of 100
Grade: B
Buy
Investment rating
4.7
Growth
C6.8
Quality
B7.5
Profitability
B+6.7
Valuation
B5/9
Piotroski F-Score
Moderate
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$48.46
+44.18%
12-Month target
$39.87
+18.63%
Intrinsic (DCF)
$47.07
Margin of safety
-8.48%
4 Strong Buy4 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 20.30% — above average
+ Free cash flow $117.22M — positive
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.14B | $1.97B | $1.98B | $2.09B | $2.09B |
| Net income | $423.21M | $341.30M | $83.59M | $424.88M | $107.83M |
| EPS | — | — | — | — | $2.04 |
| Free cash flow | $565.93M | $296.65M | $506.38M | $453.28M | $117.22M |
| Profit margin | 19.76% | 17.37% | 4.23% | 20.33% | 20.30% |
Peer comparison
Smart narrative
Qiagen NV trades at $33.61. representing a P/E of 16.48x trailing earnings. Our Smart Value Score of 73/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.58, it sits in the grey zone. TTM revenue stands at $2.09B. with profit margins at 20.30%. Our DCF model estimates intrinsic value at $47.07.
Frequently asked questions
What is Qiagen NV's stock price?
Qiagen NV (QGEN) trades at $33.61.
Is Qiagen NV overvalued?
Smart Value Score 73/100 (Grade B, Buy). DCF value $47.07.
What is the price target of Qiagen NV (QGEN)?
The analyst target price is $48.46, representing +44.2% upside from the current price of $33.61.
What is the intrinsic value of Qiagen NV (QGEN)?
Based on our DCF model, intrinsic value is $47.07, a -8.5% margin of safety versus $33.61.
What is Qiagen NV's revenue?
TTM revenue is $2.09B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
2.58 — grey zone.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.31x
ROE11.60%
Beta0.79
50D MA$42.21
200D MA$46.36
Shares out0.21B
Float0.20B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—